Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-08-01 Paradigm Biocapital Advisors LP 10% owner Sale −1,870,499 $14.92 $27.9M 4,720,482
2024-08-01 Paradigm Biocapital Advisors LP 10% owner Sale −529,501 $14.92 $7.9M 783,118
2023-12-06 Paradigm Biocapital Advisors LP 10% owner Purchase +100,000 $11.60 $1.2M 6,590,981

Page 1 of 1 · 3 trades